Etoricoxib cost effective for ankylosing spondylitis in the UK

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.600, 2010-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Etoricoxib and the treatment of ankylosing spondylitis

By Lories Rik J

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 12, 2012-12 ,pp. : 1599-1608

Informa Healthcare

Access to resources Recommend Favorite

Cost Effectiveness of Etoricoxib versus Celecoxib and Non-Selective NSAIDS in the Treatment of Ankylosing Spondylitis

By Jansen Jeroen P.

PharmacoEconomics, Vol. 28, Iss. 4, 2010-04 ,pp. : 323-344

Adis International

Access to resources Recommend Favorite

Infliximab effective in ankylosing spondylitis

Inpharma, Vol. 1, Iss. 1333, 2002-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Etanercept: TNF antagonist effective in ankylosing spondylitis

Inpharma, Vol. 1, Iss. 1402, 2003-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Etoricoxib: A Review of its Use in the Symptomatic Treatment of Osteoarthritis, Rheumatoid Arthritis, Ankylosing Spondylitis and Acute Gouty Arthritis

By Croom Katherine F. Siddiqui M. Asif A.

Drugs, Vol. 69, Iss. 11, 2009-07 ,pp. : 1513-1532

Adis International

Access to resources Recommend Favorite